04-11-2024 | Vaccination | Guidelines
RSSDI update on vaccination in people with diabetes
Published in: International Journal of Diabetes in Developing Countries
Login to get accessAbstract
Background and Aim
People with diabetes are at increased risk for infections, and vaccine-preventable diseases such as pneumococcal and influenza infections pose serious complications, including increased mortality rates. Despite the benefits of vaccinations in preventing such infections and their complications, vaccine uptake among individuals with diabetes remains suboptimal, particularly in countries like India. This article aims to address the importance of vaccinations in people with diabetes, discuss various vaccine-preventable diseases, and present harmonized vaccine recommendations tailored to the Indian context.
Methods
A review of current guidelines from international health organizations such as the American Diabetes Association (ADA), Centers for Disease Control and Prevention (CDC), and Advisory Committee on Immunization Practices (ACIP) was conducted. Vaccination recommendations for pneumococcal, influenza, hepatitis B, Tdap, shingles, and respiratory syncytial virus (RSV) were evaluated, with a focus on their applicability to people with diabetes in India.
Results
Vaccines including pneumococcal polysaccharide vaccine (PPSV23) and pneumococcal conjugate vaccine (PCV13) have proven efficacy in preventing pneumococcal infections among people with diabetes. Influenza vaccines are shown to reduce all-cause mortality and prevent cardiovascular events during flu seasons. Hepatitis B, Tdap, and shingles vaccines are recommended for adults with diabetes. However, evidence reveals low vaccination coverage, particularly in India, where awareness and education regarding vaccination are lacking. The article provides harmonized vaccination recommendations specifically for the Indian context, aiming to address gaps in vaccine coverage and accessibility. The need for culturally sensitive education campaigns and healthcare provider engagement to improve vaccination rates is emphasized.
Conclusion
Vaccinations play a key role in preventing serious infections in people with diabetes, yet hesitancy and limited awareness persist, especially in India. By providing clear, country-specific guidelines and increasing education efforts, vaccine uptake can be improved, ultimately reducing the burden of preventable diseases.
